Investor insights
Sectors invested in
Funding rounds participated in
$82M sweet spot round size
Most of their 25 investments are in rounds between $69M and $120M
Investor type
Basic info
Industry
Date founded
2019
Investments made
Taysha Gene Therapies raised $150M on August 14, 2023
Investors: RTW Investments, LP, GordonMD Global Investments LP, PBM Capital Group, RA Capital Management, L.P., TCG X, The Invus Group, B Capital Group and Octagon Capital Advisors
Undisclosed raised $29M on April 12, 2023
Investors: Lilly Asia Ventures, Quan Capital 泉创资本 and Octagon Capital Advisors
禾木（中国）生物工程有限公司 raised undisclosed on January 1, 2023
Investors: Octagon Capital Advisors
ArriVent Biopharma raised $155M on December 29, 2022
Investors: Lilly Asia Ventures, Sofinnova Ventures, Russia technology fund, Sirona Capital, Sequoia Capital China, Unicorn Capital Partners 獨秀資本 and Octagon Capital Advisors
Aktis Oncology raised $84M on August 25, 2022
Investors: NS Investment, Pappas Capital, TCG X, MPM Capital, Merck Group, Vida Ventures, LLC and Octagon Capital Advisors
BlueJay Therapeutics raised $41M on August 16, 2022
Investors: RiverVest Venture Partners and Octagon Capital Advisors
ArriVent Biopharma raised $69M on February 15, 2022
Investors: Lilly Asia Ventures, Hillhouse Capital Management, OrbiMed Advisors, Boyu Capital and Octagon Capital Advisors
Undisclosed raised undisclosed on January 4, 2022
Investors: Octagon Capital Advisors
Undisclosed raised $61M on December 14, 2021
Investors: Cenova Capital, Laurion Capital Management LP, Sage Partners, - and Octagon Capital Advisors
Allorion Therapeutics raised $40M on November 24, 2021
Investors: Med-Fine Capital, 晨壹投资 Firstred Capital, 泰福资本 TF Capital, Qiming Venture Partners, IDG Capital Partners and Octagon Capital Advisors